David D. Chang - May 16, 2024 Form 4 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role
President and CEO, Director
Signature
/s/Earl Douglas, Attorney-in-Fact
Stock symbol
ALLO
Transactions as of
May 16, 2024
Transactions value $
$1,000,001
Form type
4
Date filed
5/20/2024, 06:01 PM
Previous filing
Mar 18, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALLO Common Stock Award $1M +345K +7.72% $2.90 4.81M May 16, 2024 Direct F1
holding ALLO Common Stock 1.2M May 16, 2024 See footnote F2
holding ALLO Common Stock 856K May 16, 2024 See footnote F3
holding ALLO Common Stock 856K May 16, 2024 See footnote F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares of common stock were acquired directly from Allogene Therapeutics, Inc (the "Issuer") in a registered direct offering.
F2 Securities held in the name of the Chang 2006 Family Trust
F3 Securities held in the name of the JEC 2019 Trust dated October 1, 2019.
F4 Securities held in the name of the RTC 2019 Trust dated October 1, 2019.